Table 3.
Meta-analysis of the prevalence of COVID-19, mental disorders, Parkinson’s symptoms in patients with Parkinson’s disease
| Categories | Outcomes | No. study (SS) | No. of patients | Pooled prevalence | Heterogeneity assessment | ||
|---|---|---|---|---|---|---|---|
| I2 | p value | Test Q | |||||
| Outcomes of covid-19 | Covid-19 | 4 (71,261) | 761 | 1 .06% (1.03–1.1%) | 70.36% | 0.02 | 10.12 |
| Admission to Hospital | 3 (71,124) | 703 | 0.98% (0.91–1.7%) | 98.05% | 0.00 | 102.70 | |
| Mental Disorder | Depression | 6 (2156) | 1104 | 46% (29–64%) | 98.33% | 0.00 | 299.13 |
| Anxiety | 6 (1795) | 864 | 43% (24–63%) | 98.37% | 0.00 | 307.53 | |
| Parkinson’s symptoms | The physical activity | 5 (1352) | 768 | 57% (45–67%) | 92.96% | 0.00 | 56.83 |
| Tremor | 4 (1998) | 976 | 68% (35–94%) | 99.54% | 0.00 | 649.51 | |
| Dyskinesia | 3 (1898) | 866 | 50% (21–79%) | 99.45% | 0.00 | 362.97 | |
| Rigidity | 2 (598) | 458 | 79% (76–83%) | 0.00 | 0.00 | 51.80 | |
| Gait impairments | 2 (932) | 377 | 43% (40–46%) | 0.00 | 0.00 | 41.26 | |
| Freezing of gait | 2 (1330) | 555 | 42% (39–44%) | 0.00 | 0.00 | 49.73 | |
| Sleep problems | 6 (1725) | 898 | 72% (45–92%) | 99.08% | 0.00 | 545.45 | |